Literature DB >> 9804181

Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures.

C E van Roozendaal1, A J Gillis, J G Klijn, B van Ooijen, C J Claassen, A M Eggermont, S C Henzen-Logmans, J W Oosterhuis, J A Foekens, L H Looijenga.   

Abstract

Insulin-like growth factors are involved in the paracrine growth regulation of human breast tumor cells. IGF2 is imprinted in most tissues, and shows expression of the paternal allele only. To investigate whether disruption of this monoallelic IGF2 expression is involved in breast cancer development, a series of primary tumors and adjacent, histologically normal, breast tissue samples, as well as matched primary in vitro fibroblast cultures were studied. Biallelic expression (partial) of IGF2 was found in the majority of in vivo samples, and corresponding fibroblast cultures, while monoallelic expression was found in a normal breast sample. In contrast, H19, a closely apposed, but reciprocally imprinted gene, assumed to be regulated by a common control element, showed retention of monoallelic H19 expression in all in vivo and in the majority of in vitro samples. These data indicate that IGF2, but not H19, is prone to loss of imprinting in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804181     DOI: 10.1016/s0014-5793(98)01211-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Patient-derived xenograft models in gynecologic malignancies.

Authors:  Clare L Scott; Helen J Mackay; Paul Haluska
Journal:  Am Soc Clin Oncol Educ Book       Date:  2014

Review 2.  Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.

Authors:  Mónica Enguita-Germán; Puri Fortes
Journal:  World J Hepatol       Date:  2014-10-27

3.  Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer.

Authors:  Preetha J Shetty; Sireesha Movva; Nagarjuna Pasupuleti; Bhavani Vedicherlla; Kiran K Vattam; Sambasivan Venkatasubramanian; Yog R Ahuja; Qurratulain Hasan
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-27       Impact factor: 4.553

Review 4.  Insulin and IGFs in obesity-related breast cancer.

Authors:  Valentina Belardi; Emily J Gallagher; Ruslan Novosyadlyy; Derek LeRoith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-24       Impact factor: 2.673

5.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

6.  Breast cancer micrometastases: different interactions of carcinoma cells with normal and cancer patients' bone marrow stromata.

Authors:  Maria-Helena A Nicola; Rosana Bizon; Janaina J S Machado; Tereza Sollero; Renato S Rodarte; João S Nobre; Maurício M Magalhães; Christina M Takiya; Radovan Borojevic
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 7.  Roles of lncRNA in breast cancer.

Authors:  Yin Liu; Sambad Sharma; Kounosuke Watabe
Journal:  Front Biosci (Schol Ed)       Date:  2015-06-01

8.  Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouse.

Authors:  D N Church; B R Phillips; D J Stuckey; D J Barnes; F M Buffa; S Manek; K Clarke; A L Harris; E J Carter; A B Hassan
Journal:  Oncogene       Date:  2011-11-28       Impact factor: 9.867

9.  Impact of body mass index on breast cancer in accordance with the life-stage of women.

Authors:  Reiko Suzuki; Shigehira Saji; Masakazu Toi
Journal:  Front Oncol       Date:  2012-10-04       Impact factor: 6.244

10.  Leukocyte DNA as surrogate for the evaluation of imprinted Loci methylation in mammary tissue DNA.

Authors:  Ludovic Barault; Rachel E Ellsworth; Holly R Harris; Allyson L Valente; Craig D Shriver; Karin B Michels
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.